UnitedHealth Group Stock Trades Below Consensus Targets Amid Year-To-Date Underperformance

UnitedHealth Group Inc., a leading healthcare provider, is currently trading below its average analyst price target. According to market data as of August 19, 2026, the company's stock closed at $388.03 on the New York Stock Exchange, with an extended-hours indication of $388.62 later that evening.

The same dataset shows a forecasted upside of 17.50 percent from the close at $388.03 to the average analyst price target of $455.92, underlining that the current market price is meaningfully below where analyst models see the shares in the medium term.

A separate market snapshot framed around the CBOE listing of UnitedHealth Group shares shows a reference price of $384.73 in U.S. dollars as of August 20, 2026, with a five-day percentage change of -0.98 percent and a year-to-date change of -4.21 percent.

The stock has underperformed a related benchmark comparison by more than 20 percentage points in 2026, raising questions about whether the current price reflects transitory concerns or a more structural reset of expectations.